companydata.dkBILLEV PHARMA ApS: Financial statements 2024
CVR: 81814813
BILLEV PHARMA ApS (CVR 81814813) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 24,763,226 and a net result of DKK 3,378,539 compared with DKK 4,943,056 the year before. That is a decrease of 14.8% compared with the year before. Equity amounted to DKK 3,698,539. The solvency ratio was 53.5%. The company had 19 employees in the financial year.
- Gross Profit
- 24,763,226 kr.
- Profit/Loss
- 3,378,539 kr.
- Equity
- 3,698,539 kr.
- Total Assets
- 6,910,953 kr.
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 24.8 mio. | 3.4 mio. | 3.7 mio. | 19 |
| 2023 | - | 29.1 mio. | 4.9 mio. | 5.3 mio. | 21 |
| 2022 | - | 30.2 mio. | 6 mio. | 6.3 mio. | 21 |
| 2021 | - | 25.6 mio. | 5.5 mio. | 5.9 mio. | 19 |
| 2020 | - | 21.4 mio. | 3.8 mio. | 4.1 mio. | 16 |
How creditworthy is BILLEV PHARMA ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout BILLEV PHARMA ApS
BILLEV PHARMA ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 1977. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Ulrikke Lynge Jensen and Anja Wencke van Arkens. The company is owned by VAN ARKENS HOLDING ApS and UL JENSEN HOLDING ApS. The company has 15 employees. In 2026, the company reported a gross profit of DKK 38,801,270 and a net result of DKK 10,205,639 compared with DKK 6,143,854 the year before. Equity amounted to DKK 10,525,639.